Genmab A/S (GNMSF)
300.00
-8.00
(-2.60%)
USD |
OTCM |
Feb 11, 09:53
Genmab Total Assets (Quarterly) : 7.021B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ascendis Pharma A/S | 1.357B |
| Zealand Pharma A/S | 2.644B |
| Bavarian Nordic A/S | 2.386B |
| ALK-Abello A/S | 1.334B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.27B |
| Shareholders Equity (Quarterly) | 5.751B |
| Debt to Equity Ratio | 0.0247 |
| Current Ratio | 6.034 |
| Net Debt Paydown Yield | 0.00% |